Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot study-Reference-Cited by-同舟云学术

Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot study

Published:2012-03-01 Issue:6 Volume:69 Page:1457-1466
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Jansen Robert S.,Rosing Hilde,Wijermans Pierre W.,Keizer Ron J.,Schellens Jan H. M.,Beijnen Jos H.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-012-1850-x.pdf

Reference53 articles.

1. Aparicio A, Eads CA, Leong LA, Laird PW, Newman EM, Synold TW et al (2003) Phase I trial of continuous infusion 5-aza-2′-deoxycytidine. Cancer Chemother Pharmacol 51:231–239

2. Beausejour CM, Gagnon J, Primeau M, Momparler RL (2002) Cytotoxic activity of 2′,2′-difluorodeoxycytidine, 5-aza-2′-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene. Biochem Biophys Res Commun 293:1478–1484

3. Cashen AF, Shah AK, Todt L, Fisher N, DiPersio J (2008) Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Cancer Chemother Pharmacol 61:759–766

4. Chabot GG, Bouchard J, Momparler RL (1983) Kinetics of deamination of 5-aza-2′-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside. Biochem Pharmacol 32:1327–1328

5. Cihak A (1978) Transformation of 5-aza-2′-deoxycytidine-3H and its incorporation in different systems of rapidly proliferating cells. Eur J Cancer 14:117–124

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA methyltransferase inhibitor exposure–response: Challenges and opportunities;Clinical and Translational Science;2023-06-21

2. Is Monitoring of the Intracellular Active Metabolite Levels of Nucleobase and Nucleoside Analogs Ready for Precision Medicine Applications?;European Journal of Drug Metabolism and Pharmacokinetics;2022-08-01

3. Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action;Clinical Pharmacokinetics;2020-10-16

4. Mass balance and metabolite profiling of 14C-guadecitabine in patients with advanced cancer;Investigational New Drugs;2019-10-11

5. Development, validation, and clinical application of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of total intracellular β-decitabine nucleotides and genomic DNA incorporated β-decitabine and 5-methyl-2′-deoxycytidine;Journal of Pharmaceutical and Biomedical Analysis;2019-02